As of 2024-12-15, the EV/EBITDA ratio of OptiBiotix Health PLC (OPTI.L) is -14.18. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. OPTI.L's latest enterprise value is 18.22 mil GBP. OPTI.L's TTM EBITDA according to its financial statements is -1.28 mil GBP. Dividing these 2 quantities gives us the above OPTI.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.2x - 11.5x | 10.2x |
| Forward P/E multiples | 10.6x - 14.8x | 12.1x |
| Fair Price | (14.57) - (15.87) | (15.40) |
| Upside | -168.7% - -174.9% | -172.6% |
| Date | EV/EBITDA |
| 2024-12-12 | -12.83 |
| 2024-12-11 | -13.35 |
| 2024-12-10 | -10.86 |
| 2024-12-09 | -10.58 |
| 2024-12-06 | -11.27 |
| 2024-12-05 | -13.00 |
| 2024-12-04 | -11.38 |
| 2024-12-03 | -11.44 |
| 2024-12-02 | -11.10 |
| 2024-11-29 | -12.31 |
| 2024-11-28 | -11.27 |
| 2024-11-27 | -9.37 |
| 2024-11-26 | -8.68 |
| 2024-11-25 | -8.33 |
| 2024-11-22 | -8.16 |
| 2024-11-21 | -7.98 |
| 2024-11-20 | -8.50 |
| 2024-11-19 | -8.68 |
| 2024-11-18 | -8.68 |
| 2024-11-15 | -8.85 |
| 2024-11-14 | -8.85 |
| 2024-11-13 | -9.02 |
| 2024-11-12 | -8.16 |
| 2024-11-11 | -8.16 |
| 2024-11-08 | -8.16 |
| 2024-11-07 | -8.16 |
| 2024-11-06 | -8.24 |
| 2024-11-05 | -7.46 |
| 2024-11-04 | -6.60 |
| 2024-11-01 | -6.60 |
| 2024-10-31 | -6.86 |
| 2024-10-30 | -6.77 |
| 2024-10-29 | -7.46 |
| 2024-10-28 | -7.98 |
| 2024-10-25 | -8.16 |
| 2024-10-24 | -7.81 |
| 2024-10-23 | -6.60 |
| 2024-10-22 | -7.15 |
| 2024-10-21 | -8.33 |
| 2024-10-18 | -8.50 |
| 2024-10-17 | -8.94 |
| 2024-10-16 | -9.54 |
| 2024-10-15 | -9.71 |
| 2024-10-14 | -9.71 |
| 2024-10-11 | -9.71 |
| 2024-10-10 | -9.37 |
| 2024-10-09 | -9.20 |
| 2024-10-08 | -9.02 |
| 2024-10-07 | -9.40 |
| 2024-10-04 | -9.71 |